{
  "sector": "Healthcare",
  "fullTimeEmployees": 24328,
  "longBusinessSummary": "Sino Biopharmaceutical Limited, together with its subsidiaries, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. The company operates in three segments: Chinese Medicines, Investment, and Others. Its principal products include hepatitis medicines, such as Tianqingganmei injections and Tianqingganping enteric capsules; oncology medicines comprising Saiweijian injections, Yinishu tablets, Shoufu tablets, Anxian capsules, and Qianping injections; cardio-cerebral medicines, including Yilunping tablets, Tuotuo tablets, and Kaina tablets; and orthopedic medicines, such as Gaisanchun capsules and Yigu injections. The company's principal products also comprise digestive system medicines that consist of Aisuping injections, Getai tablets, and Deyou granules; anti-infectious medicines that include Tiance injections, Tianjie injections, and Tianli injections; respiratory system medicines, such as Tianqingsule inhalation powder; and others comprising Debaian cataplasms. In addition, it engages in property holding activities; the retail and distribution of pharmaceutical products; optometry for optical glasses and sale of ophthalmic products; the provision of medical management consultancy services; and outpatient and surgical procedure. Further, the company manufactures, sells, and distributes health food; and develops medical technology. Sino Biopharmaceutical Limited was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.",
  "city": "Wan Chai",
  "phone": "852 2802 9886",
  "country": "Hong Kong",
  "companyOfficers": [],
  "website": "http://www.sinobiopharm.com",
  "maxAge": 1,
  "address1": "Office Tower",
  "fax": "852 2880 0847",
  "industry": "Biotechnology",
  "address2": "Unit 09, 41st Floor, Room 4109 Convention Plaza 1 Harbour Road",
  "previousClose": 0.945,
  "regularMarketOpen": 0.96,
  "twoHundredDayAverage": 1.1603956,
  "trailingAnnualDividendYield": 0.013756614,
  "payoutRatio": 0.183,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.96,
  "navPrice": null,
  "averageDailyVolume10Day": 275,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.945,
  "fiftyDayAverage": 0.94257575,
  "trailingAnnualDividendRate": 0.013,
  "open": 0.96,
  "averageVolume10days": 275,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": 0.01,
  "exDividendDate": 1607644800,
  "beta": 0.668028,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.96,
  "priceHint": 4,
  "currency": "USD",
  "trailingPE": 29.090908,
  "regularMarketVolume": 1040,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 17545056256,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 18585,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.96,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 1040,
  "fiftyTwoWeekHigh": 2,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": 0.69,
  "fiftyTwoWeekLow": 0.84,
  "bid": 0,
  "tradeable": false,
  "dividendYield": 0.0109,
  "bidSize": 0,
  "dayHigh": 0.96,
  "exchange": "PNK",
  "shortName": "SINO BIOPHARMACEUTICAL",
  "longName": "Sino Biopharmaceutical Limited",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": true,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "SBMFF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_7654965",
  "uuid": "6ff7105f-1dbd-3409-8fc3-9eb8796792d4",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0.09991,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 18861500416,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": 0.25,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.15902,
  "netIncomeToCommon": null,
  "trailingEps": 0.033,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": 3.84,
  "heldPercentInsiders": 0.47494,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 9837689561,
  "enterpriseValue": 17767065600,
  "threeYearAverageReturn": null,
  "lastSplitDate": 1595203200,
  "lastSplitFactor": "3:2",
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": -0.214,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.96,
  "logo_url": "https://logo.clearbit.com/sinobiopharm.com"
}